TrialInternational journal of clinical oncology2017

Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.

Naoki Fujita et al.PubMed ↗Publisher ↗

No numbers read from the abstract.